IARS1 and Barrett esophagus: ANOVA analysis of CDX2 scores revealed a significant decrease in expression of CDX2 expression as ND-BE progressed to EAC (p = 0.01 for quartile scoring, p ≤ 0.01 for IRS scoring) (Additional file 1: Figure S1a and b).